Trial Profile
Pharmacokinetic study of Sofosbuvir or Ledipasvir/Sofosbuvir in HCV-Infected Pediatric subects Aged 3 to <6 Years Old
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Dec 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Pharmacokinetics
- 09 Dec 2018 New trial record
- 13 Nov 2018 Results presented at The Liver Meeting 2018: 69th Annual Meeting of the American Association for the Study of Liver Diseases